Molecule Details
InChIKeyAZXOTZCWQDJCLY-SJCJKPOMSA-N
Compound NamePecavaptan
Canonical SMILESC[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Homologous
Avg pChEMBL8.65
SourceChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB16279
Drug NamePecavaptan
CAS Number1914998-56-3
Groups investigational
ATC Codes nan
DescriptionPecavaptan is under investigation in clinical trial NCT03901729 (A Trial to Study BAY1753011 in Patients With Congestive Heart Failure).

Cross-references: ChemSpider: 81367663
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
P30518 AVPR2 Homo sapiens Human PF00001 9.0 IC50 ChEMBL
P37288 AVPR1A Homo sapiens Human PF00001 PF08983 8.7 IC50 ChEMBL
P30559 OXTR Homo sapiens Human PF00001 8.3 Ki ChEMBL
DrugBank Target Actions (2)
Target Gene Target Name Action Type
P30518 AVPR2 Vasopressin V2 receptor antagonist targets
P37288 AVPR1A Vasopressin V1a receptor antagonist targets